Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2019-04-10

Clinical Trial Update: Selonsertib in Adults With Pulmonary Arterial Hypertension [Phase 2]

View source ↗

Summary

Phase 2 clinical trial update for Selonsertib in adults with Pulmonary Arterial Hypertension has completed enrollment with results posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Selonsertib (selonsertib)

Snippet

Sponsor: Gilead Sciences | Conditions: Pulmonary Arterial Hypertension | Phase 2 | Status: COMPLETED | Results posted: 2019-04-10